Alzheimer’s patient shares new drug hopes that could treat the causes of the disease

Sky News published this video item, entitled “Alzheimer’s patient shares new drug hopes that could treat the causes of the disease” – below is their description.

Silvia Speight was diagnosed with Alzheimer’s disease four years ago, and spoke to Sky News her hope for the newest Alzheimer’s trial drug, with her daughter Tanya Ord.

Aducanumab targets amyloid – plaque that builds up in the brains of people with Alzheimer’s – helping to slow the onset of the condition.

It is the first treatment to target the cause of the disease, as existing ones only help to ease symptoms.

Sky News YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.


About This Source - Sky News

Sky News is a British free-to-air television news channel and organisation. Sky News is distributed via a radio news service, and through online channels. It is owned by Sky Group, a division of Comcast. John Ryley is the head of Sky News, a role he has held since June 2006.

Recent from Sky News:

Us forces have conducted airstrikes against houthi anti-ship missile 1

US forces have conducted airstrikes against Houthi anti-ship missile

Lammy speech repeatedly interrupted by pro-Palestinian protesters

BREAKING: Man found dead alongside young girls and woman in Norfolk named

Leave a Comment

We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.